igg4相关疾病的免疫抑制剂。

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2025-08-21 DOI:10.1002/14651858.CD016094

Giovanni Cagnotto, Rebecka Teresia Bäcklund, Anders Bengtsson, Matteo Bruschettini

引用次数: 0

摘要

目的：这是Cochrane综述（干预）的一个方案。目的如下：评估与皮质类固醇单一疗法相比，免疫抑制剂联合或不联合皮质类固醇治疗18岁及以上人群igg4相关疾病的益处和危害。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Immunosuppressants for IgG4-related disease.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of immunosuppressants with or without corticosteroids compared to corticosteroid monotherapy for the treatment of IgG4-related disease in people 18 years or older.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.